EVALUATION OF OUTCOMES OF TRANSURETHRAL SEMINAL VESICULOSCOPY IN TREATMENT OF PERSISTENT HEMATOSPERMIA AT THE CENTER OF ANDROLOGY, VIET DUC UNIVERSITY HOSPITAL IN 2025
Main Article Content
Abstract
Objectives: To describe clinical features, determine the proportion of etiologies causing persistent hematospermia diagnosed by transurethral seminal vesiculoscopy, evaluate treatment outcomes, and report complications.
Subjects and methods: Retrospective analysis of 13 male patients with persistent hematospermia (≥ 3 months) who underwent transurethral seminal vesiculoscopy at the Center of Andrology, Viet Duc University Hospital in 2025.
Results: Median age was 34 (18-53) years. The leading pre-operative diagnoses were seminal vesiculitis/vasitis (46.2%), seminal vesicle/ejaculatory duct stones (30.8%), and varicose periprostatic veins (15.4%). Endoscopy helped clarify the etiology in cases without a definite pre-operative diagnosis. All patients received definitive intervention in the same session (stone fragmentation, irrigation, vein fulguration). Median operative time was 45 minutes, and median hospital stay was 5 days (range 3-9). No intraoperative or postoperative complications were recorded; 100% of patients had complete resolution of hematospermia.
Conclusions: Transurethral seminal vesiculoscopy is a safe and effective method that allows accurate diagnosis and definitive treatment of persistent hematospermia in a single procedure.
Article Details
Keywords
Persistent hematospermia, transurethral seminal vesiculoscopy, seminal vesicle stones, seminal vesiculitis, endoscopic treatment.
References
[2] Chen W.K et al. Transurethral seminal vesiculoscopy for intractable hematospermia: experience from 144 patients. BMC Urol., 2021, 21 (1): 48. doi: 10.1186/s12894-021-00817-4.
[3] Drury R.H et al. Hematospermia etiology, diagnosis, treatment, and sexual ramifications: a narrative review. Sex. Med. Rev., 2022, 10 (4): 669-680. doi: 10.1016/j.sxmr.2021.07.004.
[4] Dittmar F et al. Comprehensive evaluation of hematospermia in patients with acute epididymitis compared to patients with isolated hematospermia. Andrology, 2024, 12 (5): 1001-1011. doi: 10.1111/andr.13489.
[5] Chen R et al. Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases. Asian J. Androl., 2018, 20 (5): 3. doi: 10.4103/aja.aja_76_17.
[6] Abdel-Al I et al. Long-term success durability of transurethral resection of ejaculatory duct in treating infertile men with ejaculatory duct obstruction. J. Endourol., 2022, 36 (7): 982-988. doi: 10.1089/end.2021.0840.
[7] Song L et al. Successful treatment of seminal vesicle calculi and prostatic utricle calculi by transurethral seminal vesiculoscopy. Andrologia, 2020, 52 (11): e13804. doi: 10.1111/and.13804
[8] Zarli M.H et al. Transurethral treatment of a seminal vesicle cyst with lithiasis: case report. Case Rep. Surg., 2025: 5599829. doi: 10.1155/cris/5599829.
[9] Zheng L et al. Azoospermia due to functional and partial ejaculatory duct obstruction: a rare case report and literature review. Andrology, 2024, 18 (5): 15579883241281668. doi: 10.1177/15579883241281668
[10] Al-Harbi A. Transurethral resection of ejaculatory ducts (TURED) for the management of ejaculatory duct obstruction: a Saudi cohort. J. Mens Health, 2023, 19 (9): 76-81. doi: 10.22514/jomh.2023.086